Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Results from a study sponsored by CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, form ...
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2016 – Study sponsor CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for...
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2016 -- Study sponsor CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for...
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2016 – CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular...
CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, announces that the European Society of ...
CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, fulfills enrollment for its Phase IIa...
CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, welcomes MedStar...
CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to proceed with ...
CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, announces that...
CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that designs allogeneic stem-cell therapies for cardiovascular indications, expands...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.